New pill shows promise in battling Hard-to-Treat cancers
Disease control
Recruiting now
This study tests a new oral drug called INX-315 in 150 people with advanced breast, ovarian, or other solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and can shrink or control the cancer. Participants will receive the drug …
Phase: PHASE1, PHASE2 • Sponsor: Incyclix Bio • Aim: Disease control
Last updated May 08, 2026 12:03 UTC